In October 2014, Modern Cancer Hospital Guangzhou has been accredited by JCI (Joint Commission International) of the 5th version, which assesses and evaluates with the strict standards in the world and stands for the highest level of accreditation for medical service and hospital management. This means Modern Cancer Hospital Guangzhou has become one of the most world-advanced medical institutes, whose medical safety, quality and services have met the highest international standards.
What is JCI?
JCI is the abbreviation of Joint Commission International. Founded in 1994, it aims to improve the global patients’ safety and quality of medical services. Thus, safety, quality and service are JCI’s core of inspection aspects. JCI makes a series of strict and concrete systems to standardize service process so as to minimize the medical errors, guarantee patients’ safety and improve medical quality.
JCI standard is taken as an authority around the world, which represents the highest level of medical services and hospital management. The JCI accreditation not only means that the hospital’s medical services has already reached the international level, but also shows the hospital’s solemn promise to continuously improve the safety and quality of patient care.
Process of JCI Accreditation
In 2005, Jacques Santer, the Chairman of the EU-China Joint Chamber of Commerce and former Chairman of European Union, visited Guangzhou and designated Modern Cancer Hospital Guangzhou as the only member hospital of EU-China Joint Chamber of Commerce.
In 2005, Modern Cancer Hospital Guangzhou has been accredited by EU-China Joint Chamber of Commerce and designated as the only member hospital of EU-China Joint Chamber of Commerce in southern China.
In 2007, Modern Cancer Hospital Guangzhou became the friendship hospital of Indonesian Yogyakarta International Hospital.
In 2009, Chairman Lin Zhicheng of Boai (China) Enterprise Group was invited to visit Egypt. See the joint photo of Chairman Lin Zhicheng and officials of Egyptian Ministry of Health.
On August 21, 2010, the 21st World Cancer Conference was held in China. Media of Indonesia, Vietnam and other countries interviewed the Chairman Lin Zhicheng of Boai (China) Enterprise Group to understand advanced minimally invasive techniques.
On August 19, 2011, "Boai Modern Charity Foundation" of Modern Cancer Hospital Guangzhou was officially launched. The financial aid was to help foreign cancer patients.
In 2012, Modern Cancer Hospital Guangzhou was invited by the Vietnamese Health Department to visit Vietnam. Modern Cancer Hospital Guangzhou received warm reception and signed a cooperation agreement with Vietnamese Chang'an Hospital, becoming permanent partners.
On March 27, 2012, Chairman Lin Zhicheng of Boai (China) Enterprise Group met Indonesian Navy Chief of Staff--- SUPARNO in Jakarta. The two sides exchanged views on further cooperation and development projects of health care.
On March 20, 2013, Filipino-Chinese Shin Lian Association established permanent partnership with Boai (China) Enterprise Group.
From May 30 to June 3 in 2014, the Fiftieth American Society of Clinical Oncology (ASCO) Annual Meeting was held at McCormick Place Chicago, USA. Modern Cancer Hospital Guangzhou was invited and Professor Peng Xiaochi, Director of Oncology Department of Modern Cancer Hospital Guangzhou, participated in this distinguished meeting and delivered an important speech.
On September 9th, the Ninth Asia Brand Ceremony was held at Hong Kong. Due to high-quality international medical technology and service, Modern Cancer Hospital Guangzhou was awarded the distinguished titles of “Top Ten Asia Brand Innovative Enterprises” and “Top Ten Leading Brand in China”. General Manger of Modern Cancer Hospital Guangzhou, Lin Shaohua, was awarded a distinguished title of “Top Ten Innovative People of Chinese (Industry) Brand”.
On April 12, 2015, the first “ASEAN Academic Committee of Minimally Invasive Therapy of Tumor” was successfully held at Ayodya Resort Baili.
*Surgery, in addition to the appropriate chemotherapy and radiotherapy, are effective in treating early cancer, but certain patients in late stage of cancer may not be tolerate surgery well as they can be relatively weak. A combination of carefully planned minimally invasive therapy, chemotherapy or radiotherapy can effectively reduce the side effects and discomfort of treatment and may help patient get better efficacy.